The global oral thrush market is expected to grow at a 4.4% CAGR over the forecast period from 2017 to 2023, according to the latest research report from Market Research Future (MRFR). The global oral thrush market is deeply analyzed in the report, which touches upon all the pertinent details concerning the market, including its leading drivers and restraints, major economic factors around the market, and major players operating in the market. The competitive landscape of the global oral thrush market is explained in detail in the report with the help of company profiles of the leading market players, which includes a detailed overview of the strategies and tactics used by the major market players. The major drivers and restraints acting on the global oral thrush market are discussed at length in the report, which provides a clear vision of which factors are integral to the development of the market in the coming years.
Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/4417
Oral thrush is a mouth infection caused by various microorganisms in the genus Candida. As a result, the disease is also known as oral candidiasis. Oral thrush is a fungal infection and may involve C. tropicalis, C. glabrata, and C. albicans; 80% of oral thrush cases can be accounted to these three species of Candida fungi, with C. albicans alone being responsible for around 50% of the overall prevalence. Oral thrush presents as a white layer on the tongue and other parts of the mouth, in addition to dryness and scaly texture inside the mouth. Patients often describe the disease as feeling as if their mouths were made of sandpaper. The rashes and dryness caused by oral thrush may leave the individual more prone to oral injuries, further adding to the threat posed by the disease.
While oral thrush is in itself a fairly minor medical condition, the incidence of oral thrush may be associated with deeper problems regarding the individual’s immune system, as oral thrush is usually the result of immunodeficiency. The pathogens responsible for oral thrush are naturally present inside the mouths of human beings. However, their natural presence is kept in check by the body’s immune system. Deficiencies in the immune system are the primary reason for the manifestation of oral thrush. As a result, the increasing prevalence of HIV is likely to be a major driver for the oral thrush market over the forecast period. Increasing awareness about immunodeficiency disorders as well as growing government support to systematic HIV eradication are likely to remain major drivers for the oral thrush market over the forecast period.
According to MRFR, the global oral thrush market is expected to rise to a valuation of USD 9.5 billion by 2023.
Leading players in the global oral thrush market include GSK plc, Glenmark Pharmaceuticals, Bristol Laboratories, Ranbaxy Laboratories Limited, Wockhardt Ltd., Pfizer Inc., Stellar Pharma, Teva Pharmaceuticals, and Bayer AG. Major players in the oral thrush market are likely to focus on the development of effective remedies in multiple forms such as creams and lotions, pills, etc. Increasing the accessibility of oral thrush medication to consumers is likely to be a major strategy for players in the oral thrush market, resulting in the growing demand to make oral thrush products available in various formats, so that the products are available to various consumer demographics. Research and development into producing more effective oral thrush remedies is also likely to be a key tactic for players in the global oral thrush market over the forecast period.
The global oral thrush market has been segmented on the basis of type, diagnosis, treatment, end user, and region.
Based on type, the oral thrush market has been segmented as pseudomembranous, erythematous, hyperplastic, and others. The pseudomembranous segment is likely to hold the major share in the global oral thrush market in the coming years, followed by the erythematous segment.
Based on diagnosis, the market has been segmented as examination, biopsy, endoscopy, and others.
Based on treatment, the market has been segmented as anti-fungal treatment, immune-modulators, and others.
Based on end use, the market has been segmented as hospitals & clinics, academic and research, and others.
The Americas is likely to hold the largest share in the global oral thrush market, followed by Europe. Asia Pacific follows Europe and is likely to exhibit robust growth due to the rapid growth of the healthcare sector in the region. The Middle East and Africa is the smallest regional market.
Browse Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/oral-thrush-market-4417
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar